We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Gilberto Lopes

Gilberto de Lima Lopes Jr., MD, MBA, FAMS

Medical Director for International Programs and Associate Director for Global Oncology, Sylvester Comprehensive Cancer Center; Associate Professor, University of Miami Miller School of Medicine

Dr. Gilberto Lopes, an expert in medical oncology in low- and middle-income countries, is Medical Director for International Programs and Associate Director for Global Oncology at the Sylvester Comprehensive Cancer Center and Associate Professor at the University of Miami Miller School of Medicine. He is an associate editor for ASCO University and for ASCO’s Journal of Global Oncology. From 2006 to 2013, Dr. Lopes worked for the Johns Hopkins University Singapore International Medical Center, and, prior to that, was the Chief Medical and Scientific Officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

Dr. Lopes has published widely, with more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, The Lancet, The Lancet Oncology, and Nature Reviews, and has lectured nationally and internationally. He has been principal or co-principal investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary, and thoracic cancers. His areas of research interest extend to health economics, value, policy, and access to cancer drugs and treatment in low- and middle-income countries. He has served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization.

After graduating from medical school in Brazil, Dr. Lopes received residency training in internal medicine and completed a fellowship in hematology/oncology at the University of Miami.

Disclosures

Honoraria

Company: AstraZeneca

Company: Roche/Genentech

Company: Merck Serono

Company: Merck Sharp & Dohme

Company: Fresenius Kabi

Company: Novartis

Company: Bristol-Myers Squibb

Company: Janssen-Cilag

Company: Boehringer Ingelheim

Company: Pfizer

Company: CIPLA

Company: Sanofi

Company: Eisai

Company: Lilly

 

Consulting or Advisory Role

Company: Pfizer

Company: Bristol-Myers Squibb

Company: Lilly/ImClone

 

Research Funding

Company: Lilly/ImClone

Company: Pfizer

Company: AstraZeneca

Company: Merck Sharp & Dohme

Company: Eisai

Company: Bristol-Myers Squibb

Expert Testimony

Company: Sanofi